LEADER 01290nam2-2200409---450- 001 990001406980203316 005 20090506120225.0 035 $a000140698 035 $aUSA01000140698 035 $a(ALEPH)000140698USA01 035 $a000140698 100 $a20040210d1947----km-y0itay50------ba 101 0 $afre 102 $aFR 105 $aa|||z|||001yy 200 1 $a<>exploitation du hasard$fpar Marcel Boll 210 $aParis$cPresses universitaires de France$d1947 215 $a125 p.$cill.$d18 cm 225 2 $aQue sais-je?$v57 410 0$1001000311637$12001$aQue sais-je?$v, 57 606 0 $aProbabilità$2BNCF 676 $a519.2 700 1$aBOLL,$bMarcel$02185 801 0$aIT$bsalbc$gISBD 912 $a990001406980203316 951 $aVI.4. Coll. 22/ 8(I B Coll. 27/15)$b1014 L.M.$cVI.4. Coll.$d00166109 959 $aBK 969 $aUMA 979 $aSIAV6$b10$c20040210$lUSA01$h1030 979 $aPATRY$b90$c20040406$lUSA01$h1739 979 $aCOPAT1$b90$c20050310$lUSA01$h1145 979 $aANNAMARIA$b90$c20080609$lUSA01$h1317 979 $aANNAMARIA$b90$c20080609$lUSA01$h1318 979 $aANNAMARIA$b90$c20080612$lUSA01$h1347 979 $aANNAMARIA$b90$c20090506$lUSA01$h1202 996 $aExploitation du hasard$9929890 997 $aUNISA LEADER 01278nam 2200361Ka 450 001 9910696143603321 005 20070927171355.0 035 $a(CKB)5470000002375376 035 $a(OCoLC)173428614 035 $a(EXLCZ)995470000002375376 100 $a20070927d2006 ua 0 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDiploma mills$b[electronic resource] $edegrees of deception 210 1$a[Washington, D.C.] :$cFederal Trade Commission, Bureau of Consumer Protection, Office of Consumer & Business Education,$d[2006] 215 $a2 unnumbered pages $cdigital, PDF file 225 1 $aFTC consumer alert 300 $aTitle from title screen (viewed on Sept. 27, 2007). 300 $a"October 2006"--P. [2]. 517 $aDiploma mills 606 $aDiploma mills$zUnited States 606 $aUniversities and colleges$xCorrupt practices$zUnited States 615 0$aDiploma mills 615 0$aUniversities and colleges$xCorrupt practices 712 02$aUnited States.$bFederal Trade Commission.$bOffice of Consumer and Business Education. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910696143603321 996 $aDiploma mills$93438475 997 $aUNINA LEADER 02141nam 2200457z- 450 001 9910261143503321 005 20210211 035 $a(CKB)4100000002484657 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/43699 035 $a(oapen)doab43699 035 $a(EXLCZ)994100000002484657 100 $a20202102d2017 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aComputational and Experimental Approaches in Multi-Target Pharmacology 210 $cFrontiers Media SA$d2017 215 $a1 online resource (122 p.) 225 1 $aFrontiers Research Topics 311 08$a9782889452521 311 08$a2889452522 330 $aThe next frontier in pharmacology is the development of multi-target strategies in which pathological processes are controlled by pharmacologically manipulating them at many different points at once. Designing multi-target strategies will require deep understanding of the complex physiology that underlies pathological processes. It will also require the development of single drugs with multiple targets, or combinations of drugs with compatible pharmacokinetics that work synergistically to maximize desirable effects while minimizing unwanted side effects. This e-Book contains ten original articles, each addressing a different aspect of this challenge. Together they open new perspectives and show the way forward in the development of multi-target therapeutics. 606 $aPharmacology$2bicssc 610 $acomputer modeling 610 $adrug combination 610 $adrug discovery 610 $adrug repurposing 610 $ahigh throughput screening 610 $amultidrug therapeutics 610 $amultifactorial process 610 $apolypharmacy 610 $asynergy 610 $asystems biology 615 7$aPharmacology 700 $aAnastasio$b Thomas J$4auth$01797439 906 $aBOOK 912 $a9910261143503321 996 $aComputational and Experimental Approaches in Multi-Target Pharmacology$94339683 997 $aUNINA